Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gayatri BioOrganicsBOM:524564 8 Receivables Turnover is 9.21 as of Jun. 2026. GuruFocus rates BOM:524564 with a GF Score™ of 8/100. The stock has 3 warning signs investors should review. Among 1,585 Chemicals companies, Gayatri BioOrganics ranks better than 78.49% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Gayatri BioOrganics's Revenue for the
three
months ended in Jun. 2026 was ₹23.37 Mil. Gayatri BioOrganics's average Accounts Receivable for the
three
months ended in Jun. 2026 was ₹2.54 Mil.
Hence, Gayatri BioOrganics's Receivables Turnover for the
three
months ended in Jun. 2026 was 9.21.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Gayatri BioOrganics Receivables Turnover Related Terms
Gayatri BioOrganics Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Gayatri BioOrganics's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524564 vs DOW: Receivables Turnover Comparison
For the Chemicals subindustry, Gayatri BioOrganics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gayatri BioOrganics Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Gayatri BioOrganics's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Gayatri BioOrganics's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gayatri BioOrganics (BOM:524564) has a Receivables Turnover of 9.21 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Gayatri BioOrganics and its competitors. According to the industry distribution chart, Gayatri BioOrganics ranks #341 out of 1585 companies in the Chemicals industry, placing it in the top 21.5%.
Is Gayatri BioOrganics' Receivables Turnover too high?
Gayatri BioOrganics' current Receivables Turnover is 9.21. The Chemicals industry median Receivables Turnover is 5.76. Gayatri BioOrganics' value of 9.21 is 59.9% above this industry median. Based on the distribution chart, Gayatri BioOrganics ranks #341 out of 1585 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Gayatri BioOrganics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Gayatri BioOrganics' Receivables Turnover compare to DOW?
According to the Chemicals industry distribution chart, Gayatri BioOrganics ranks #341 out of 1585 companies for Receivables Turnover. This places Gayatri BioOrganics in the top 22% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.76. Gayatri BioOrganics' value of 9.21 is 59.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.76, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gayatri BioOrganics's current Receivables Turnover of 9.21 is 59.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Gayatri BioOrganics and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gayatri BioOrganics's current Receivables Turnover is 9.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gayatri BioOrganics stock overvalued right now?
Gayatri BioOrganics (BOM:524564) has a current Receivables Turnover of 9.21. The current Receivables Turnover is 9.21 and 59.9% above the Chemicals industry median of 5.76. Gayatri BioOrganics' overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Gayatri BioOrganics (BOM:524564), the current Receivables Turnover is 9.21 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gayatri BioOrganics Ltd is engaged in the manufacturing of starch, modified starches, liquid glucose, sorbitol, and its allied products, and trading in maize. Other products offered by the company include corn fiber, germ, gluten, Bio-oxide-G, Bio-theen-G, Bio-y-dext, and Bio-w-dext. It is one of the manufacturing units of Starch, Modified Starches ,Liquid Glucose, Sorbitol, and its allied products in south India with a wide distribution network across the country.
8GF Score
Get the complete analysis for BOM:524564
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524564 has been successfully added to your 
